Heterocyclic benzoxazole-based liquid crystals

The synthesis, characterization, and mesomorphic properties of a new type of heteronuclear compounds 1a-c and a Pd complex 1d derived from benzoxazole as the core group are reported. These compounds were prepared by the ring closure reaction of 4-alkoxybenzoic acid 4-[(4-alkoxy-2-hydroxyphenylimino)methyl]phenyl esters 6 in the presence of lead(IV) acetate. All the compounds were characterized by ¹H and ¹³C NMR spectroscopies and elemental analysis. The phase behaviour of these mesogenic compounds was characterized and studied by differential scanning calorimetry and polarizing optical microscopy. All the compounds 1a exhibited nematic (N) and/or smectic C (SmC) phases, as expected for rod-like molecules; however, the compounds 1b and 1c exhibited crystal phases. For those compounds 1a having shorter carbon chains (n = 1, 3, 4) nematic phases were observed, whereas for compounds having longer carbon chains (n = 6, 7, 8, 10, 12, 14) smectic C behaviour was also observed at lower temperatures. The greater aspect ratio (l/d) of compounds 1a compared with 1b and 1c was found to be required for the observation of liquid crystallinity. The fluorescent properties of these compounds were also examined. All λ_max peaks of the absorption and photoluminescence spectra of compounds 1a-1c occurred at c. 316-322 nm and 371-382 nm, respectively. The quantum yields of some compounds were relatively low, and also slightly solvent-dependent.     

Chemical composition of Argentinean propolis collected in extreme regions and its relation with antimicrobial and antioxidant activities

This paper reveals, for the first time, the functional properties of propolis from an extreme region of Argentine (El Rincón, Province of Catamarca, Argentina), as well as the isolation and identification of bioactive compounds. The antioxidant activity was determined by the ABTS method and beta-carotene bleaching. The antibacterial activity was determined on methicillin resistant Staphylococcus aureus (MRSA) by the microdilution method and bioautographic assays. Twelve compounds were isolated and identified by NMR spectroscopy. The main bioactive compounds were 2',4'-dihydroxy-3'-methoxychalcone (3), 2',4'-dihydroxychalcone (9), 2',4',4-trihydroxy-6'- methoxychalcone (8), 5-hydroxy-4',7-dimethoxyflavone (4), 4',5-dihydroxy-3,7,8-trimethoxyflavone (10) and 7-hydroxy- 5,8-dimethoxyflavone (11). All compounds were active against clinical isolates (MIC50 10 microg/mL) and displayed antioxidant activity (SC50 values of 20 microg/mL). The MIC and SC50 values of the isolated compounds were lower than those obtained with crude propolis extracts, chloroform sub-extracts and isolated fractions.     

Antimicrobial activity of some new thioureides derived from 2-(4-chlorophenoxymethyl)benzoic acid

We report here the characterisation of eight newly synthesized thioureides of 2-(4-chlorophenoxymethyl)-benzoic acid and the evaluation of the in vitro antimicrobial activity of the new compounds against Gram-positive [Listeria monocytogenes,Staphylococcus aureus, Bacillus subtilis], Gram-negative [Psedomonas aeruginosa,Escherichia coli, Salmonella enteritidis], as well as Candida spp., using both reference and clinical multidrug resistant strains to establish the minimal inhibitory concentration (MIC)values. Our results showed that the tested compounds exhibited specific antimicrobial activities, both concerning the spectrum of antimicrobial activity and the corresponding MIC values, which ranged widely between 1024 and 32 mug/mL, depending on the nature and position of the substituents on the benzene ring. The most active compounds were N-[2-(4-chlorophenoxymethyl)-benzoyl]-N'-(2,6-dichlorophenyl)-thiourea (5 g) and N-[2-(4-chlorophenoxymethyl)-benzoyl]-N'-(4-bromophenyl)-thiourea (5h), which showed a broad spectrum of antimicrobial activity against enterobacterial strains (E. coli and S. enteritidis),P. aeruginosa, S. aureus and Candida spp. All the tested compounds except 5f were highly active against S. aureus (MIC=32 mug/mL), suggesting their possible use in the treatment of MRSA infections. Four of compounds also exhibited antifungal activity (MIC =256-32 microg/mL) against C. albicans, but L. monocytogenes as well as B. subtilis were resistant to all tested compounds. Our studies thus demonstrated that among other biological activities,the thioureides of 2-(4-chlorophenoxymethyl)-benzoic acid also exhibit selective and effective antimicrobial properties that could lead to the selection and use of these compounds as efficient antimicrobial agents, especially for the treatment of multidrug resistant infections.     

New liquid crystal compounds ( )-4-[5-(2-Methylbutyl)-1,3-dioxan-2-yl]phenyl 4-alkoxybenzoate

New liquid crystal compounds, (+)-4-[5-(2-methylbutyl)-1,3-dioxan-2-yl] phenyl 4-alkoxybenzoates (5), were synthesized. The mesomorphic behaviour of these compounds is compared with that of (+)-4-(5-alkyl-1,3-dioxan-2-yl)-phenyl 4-(2-methylbutoxy)benzoates (6). While compounds 6 exhibited a chiral smectic C phase, the corresponding compounds 5 did not. This might mean that for the appearance of a chiral smectic C phase in these types of compounds, it is necessary that the carbonyl and the chiral groups exist at nearby positions. Transition temperatures to those isotropic state for compounds 5 were lower than those for compounds 6. This result is common in both cases of (+)-4-alkoxycarbonylphenyl-4-[5-(2-methylbutyl)-1,3-dioxan-2-yl]benzoates (7), and (+)-4-(2-methylbutoxy-carbonyl)phenyl 4-(5-alkyl-1,3-dioxan-2-yl)-benzoates (8).     

Heterometallic chalcogenido clusters containing lanthanides and main group metals: emissive precursors to ternary solid-state compounds

Heterometallic clusters containing lanthanides and the group 12 metals can be isolated as crystalline compounds in high yields. These products [(py)8Ln4M2Se6(SePh)4 (Ln = Er, Yb, Lu; M = Cd, Hg)] adopt a double cubane structure with the covalent M occupying an opposing pair of external metal sites. Both Er/M compounds are strongly emissive materials, with emission lifetimes of 1.41 ms (Er/Cd) and 0.71 ms (Er/Hg) and with the Er/Cd radiative quantum efficiency twice that of the Er/Hg compound. Thermal decomposition of the Er/Cd and Yb/Cd compounds at 650 degrees C give the ternary solid-state materials CdLn2Se4.     

左氧氟沙星3-芳苄叉基-喹啉-4-酮衍生物的合成及抗肿瘤活性

为进一步发现提高氟喹诺酮抗肿瘤活性的有效结构修饰策略,基于片段药物设计原理,通过喹啉-4(1H)-酮与芳香醛缩合反应合成了(S)-6-氟-7-(4-甲基-哌嗪-基)-8,1-(1,3-氧丙基)-3-芳苄叉基-2,3-二氢-喹啉-4(1H)-酮(3a-3l)目标化合物。 体外抗肿瘤活性结果表明,所合成的12个新化合物的活性均强于母体左氧氟沙星,其中F、Cl、Br取代的卤苯基化合物对人肝癌细胞株(SMMC-7721)和人胰腺癌细胞株(Capan-1)的半数抑制浓度(IC₅₀)低于其它取代基化合物,尤其是氯苯基化合物(3k)与对照抗肿瘤药阿霉素活性相当。 为此,芳苄叉基替代C-3羧基构建的3-芳苄叉基-喹啉-4-酮化合物有助于提高氟喹诺酮的抗肿瘤活性,提示α,β-不饱和酮片段作为一个有发展前景的氟喹诺酮的候选修饰基团值得进一步发展。     

1,2,7,9-四取代去氢骆驼蓬碱衍生物的合成及体外抗肿瘤活性

为了寻找高效低毒的抗肿瘤候选化合物, 以去氢骆驼蓬碱为原料, 对β-咔啉环的2-,7-和9-位3个结构位点进行了结构改造, 合成了11个去氢骆驼蓬碱衍生物, 化合物的结构经核磁共振、 红外光谱、 质谱及元素分析确证. 采用四甲基偶氮唑盐(MTT)法初步测试了目标化合物体外抗肿瘤(Bel-7402, 786-0, BGC-823, A375, 769-P和MCF7)活性, 结果表明化合物4a, 4b, 8a和8b具有显著的体外抗肿瘤活性.     

Dinuclear transition metal compounds of a decadentate pyrazole-containing chelating ligand. X-ray crystal structure of Co2(tthd)(ClO4)4(H2O)2(MeOH)1.75

A potentially decadentate ligand, 1,1,4,7,10,10-hexakis(3,5-dimethyl-1-pyrazolylmethyl)-1,4,7,10-tetraazadecane (tthd), has been synthesized from the reaction of tri-ethylenetetramine with six equivalents of N-hydroxymethyl-3,5-dimethylpyrazole. The tthd ligand forms coordination compounds, M₂(tthd)(ClO₄)₄(H₂O)_x, when M is Co, Ni, Cu, Zn and Cd and x = 4–8; and M₂(tthd)(A)₂(ClO₄)₂(H₂O)_x when M is Co and Ni, A is NCS or Cl, and x = 4–8. The cobalt compound, Co₂(tthd)(ClO₄)₂(H₂O)₂(MeOH)_1.75, crystallizes in the triclinic space group P1, a = 1.959(2), b = 1.5657(3), c = 2.1244(3) nm, = 105.5(1), β = 96.9(1), γ = 112.1(1). Due to severe disorder of the anions the structure could only be refined to an R_w, value of 0.099. The ligand acts as a decadentate, dinucleating ligand. The cobalt ions are distorted octahedrally surrounded by five N-atoms of the tthd ligand and an O-atom of water occupying the sixth coordination place. The other perchlorate compounds have very similar structures, as can be concluded from spectroscopic data.

In the thiocyanate and chloride compounds the anions have replaced the coordinated water molecules, resulting in octahedral Ni compounds. With Co thiocyanate, however, tthd acts as an octadentate ligand, resulting only in five-coordinated compounds.     

2,5-二取代噁唑的研究

合成了一系列2-苯基和2-取代苯基-5-(4＇-联苯基)(口恶)唑化合物,共三十二种。测定了它们的熔点,紫外吸收光谱,荧光发射光谱和激光转换效率。发现其中二十三种化合物在近紫外区有较高的激光转换效率(和PPO相比)。     

New oxo-bridged dinuclear peroxotungsten(VI) complexes: Synthesis, stability and activity in bromoperoxidation

Two new dinuclear oxo-bridged peroxo complexes of tungsten with coordinated dipeptides of the type, Na₂[W₂O₃(O₂)₄(glycyl-glycine)₂] · 3H₂O (1) and Na₂[W₂O₃(O₂)₄(glycyl-leucine)₂] · 3H₂O (2) have been synthesized from the reaction of H₂WO₄, 30% H₂O₂ and the respective dipeptide at pH ca. 2.5. Synthesis of the compounds, in addition to pH, is sensitive to reaction temperature and concentrations of the components. The compounds were characterized by elemental analysis, spectral and physico-chemical methods including thermal analysis. In the dimeric complexes the two W(VI) centres with edge bound peroxo groups are bridged by an oxo group. The dipeptides occurring as zwitterions bind the metal centers through O (carboxylate) atoms leading to hepta co-ordination around each W(VI). Thermal stability of the compounds as well as their stability in solution were determined. The compounds are highly stable toward decomposition in solutions of acidic as well as physiological pH. These compounds, besides another similar dimeric compound Na₂[W₂O₃(O₂)₄(cystine)] · 4H₂O (3) efficiently oxidized bromide to a bromination competent intermediate in phosphate buffer at physiological pH, a reaction in which only two of the peroxide groups of the complex species were found to be active. The complexes could also mediate bromination of organic substrate in aqueous-organic media.     

Three-phase solvent systems for comprehensive separation of a wide variety of compounds by high-speed counter-current chromatography

Three-phase solvent systems were efficiently utilized for high-speed counter-current chromatography (HSCCC) to separate multiple components with a wide range of hydrophobicity. The compositions of three-phase systems were optimized according to their physical parameters such as volume ratio, viscosity and specific gravity of upper (UP), middle (MP) and lower (LP) phases. The three-phase systems composed of n-hexane-methyl acetate-acetonitrile-water (4:4:3:4, v/v/v/v) was selected for HSCCC separation of a mixture of 15 standard compounds with a wide range in hydrophobicity from beta-carotene to tryptophan. The separation was initiated by filling the column with a mixture of MP and LP both as a stationary phase followed by elution with UP to separate the hydrophobic compounds. Then the mobile phase was switched to MP to elute the moderately hydrophobic compounds, and finally the polar compounds still retained in the column were fractionated by eluting the column with LP. The system successfully resolved all 15 compounds in one-step operation in 70 min.     

以含铬类水滑石型层状化合物为模板制备硫化物半导体纳米晶

采用类水滑石型混合金属氢氧化物(CdCr-LDH和ZnCdCr-LDH)为前驱体, 通过气-固反应方法, 制备了根植于层状氢氧化物层板中的硫化镉纳米晶和硫化镉/硫化锌复合纳米晶, 通过改变前驱体(CdCr-LDH)中镉和铬的摩尔比可以调控硫化镉纳米晶的粒径.     

有机胺功能化离子液体中离子型铑(Ⅲ)配合物催化的1-辛烯两相氢甲酰化反应

考察了离子型+3价铑配合物1a和2a作为催化剂前体在1-辛烯氢甲酰化反应中的催化行为. 实验结果表明, 在无助剂存在下, 配合物1a和2a表现出较差的催化性能, 而廉价低毒的有机叔胺助剂如三乙胺或N-甲基哌啶可以显著提升配合物1a和2a的催化性能, 可获得800 h^-1以上的转化频率(TOF). 当以哌啶功能化离子液体[PEmim]BF₄兼作助剂和溶剂时, 不仅可以促进配合物1a和2a对氢甲酰化反应的活性和选择性, 还可实现“离子液体-有机”两相氢甲酰化反应, 使得锁定在[PEmim]BF₄离子液体相中的配合物1a(或2a)催化剂得以简单两相分离和回收循环使用, 但在5次循环使用过程中锁定在[PEmim]BF₄中的催化剂存在向有机相流失和失活的问题, 导致产物壬醛的收率逐渐下降.     

Synthesis, biological and computational study of new Schiff base hydrazones bearing 3-(4-pyridine)-5-mercapto-1,2,4-triazole moiety

A series of new Schiff base hydrazones (compounds 1-16) were synthesized by condensation reaction of 4-amino-3-(4-pyridine)-5-mercapto-1,2,4-triazole with various aldehydes and/or dialdehydes. The structure of the prepared compounds was confirmed by means of 1H NMR, 13C NMR, UV-vis, IR and elemental analyses. The all prepared compounds were assayed for antibacterial (Escherichia coli and Staphylococcus aureus) and antifungal (Candida albicans) activities by disc diffusion method. The results indicate that all tested compounds did not show any antibacterial activity against E. coli, as gram negative bacteria, and antifungal activity against C. albicans. But the compounds 2, 3, 4, 6 and 8 containing 4-Cl, 4-Me, 4-MeO, 2,4-di-Cl and 2-OH substituted phenyl moiety, respectively, showed good inhibition against S. aureus as compare to standard drugs. The structure of all biologically active compounds has also been theoretically studied by ab initio Hartree-Fock (HF) methods.     

Preparative isolation of procyanidins from grape seed extracts by high-speed counter-current chromatography

High-speed counter-current chromatography (HSCCC) has been applied to the separation of grape seed procyanidins. The isolation of dimeric to tetrameric procyanidins is achieved after removing the polymeric compounds by solvent precipitation. An additional clean-up by solid-phase extraction on polyamide improved the purities of the isolated compounds. The solvent systems ethyl acetate/2-propanol/water (40:1:40, v/v/v), ethyl acetate/2-propanol/water (20:1:20, v/v/v), and ethyl acetate/1-butanol/water (14:1:15, v/v/v) were successfully used for the fractionation. The combination of HPLC-MS, diode array detection, and NMR analysis, as well as phloroglucinolysis, confirmed the structures of the isolated compounds: B1 [EC-(4beta-->8)-C], B2 [EC-(4beta-->8)-EC], B3 [C-(4alpha-->8)-C], B4 [C-(4alpha-->8)-EC], B5 [EC-4beta-->6-EC], B7 [EC-(4beta-->8)-C], [ECG-(4beta-->8)-C], trimeric procyanidin C1 [EC-4beta-->8-EC-4beta-->8-EC], and the tetrameric procyanidin cinnamtannin A2 (where C: catechin, EC: epicatechin and ECG: epicatechin-3-O-gallate).     

2-位或4-位取代吡啶并嘧啶类非经典叶酸拮抗剂的合成及抗肿瘤活性

以非经典叶酸拮抗剂2,4-二氨基-6-(4-甲基苯基)乙基吡啶并[3,2-d]嘧啶(wm-5b)及其侧链简化产物2,4-二氨基吡啶并[3,2-d]嘧啶为先导化合物, 选取具有抗肿瘤活性的基团, 通过微波法高效合成了2-位或4-位取代吡啶并嘧啶类非经典叶酸拮抗剂, 研究了2-位及4-位取代基对抗肿瘤活性的影响, 为非经典叶酸拮抗剂的设计合成提供了更多的理论依据. 目标化合物的结构均经核磁共振波谱(NMR)和质谱(MS)确证. 生物活性测定结果表明, 所有目标化合物均具有抗肿瘤活性, 其中, 6-(4-甲基苯基)乙基-4-氨基-2-(3-氯-4-氟苯基)氨基吡啶并[3,2-d]嘧啶(6b)对HL-60细胞的IC₅₀=(4.09±0.48) μmol/L, 对A549细胞的IC₅₀=(17.99±7.20) μmol/L, 而对HCT116细胞的IC₅₀=(14.52±4.74) μmol/L; 部分目标化合物具有二氢叶酸还原酶抑制活性. 此外, 对部分目标化合物和先导物进行了二氢叶酸还原酶晶体结构的分子对接, 对活性结果和构效关系从分子水平上进行解释.     

Synthesis,Docking and Biological Evaluation of Isoquinolonic Acid Derivatives

A series of isoquinolonic acid derivatives（4a-4o） was synthesized via one-pot synthesis for their anti-tumor activity. The structures of all the targeted compounds were confirmed by IH nuclear magnetic resonance （IH NMR） spectrometry and mass spectrometry（MS）. The anti-tumor activities of compounds 4a-4o against MG63（human osteosarcoma cells） and B16-F10（mouse melanoma cells） were examined. To evaluate the antitumor effect of the as-synthesized compounds, we compared the half maximal inhibitory concentration（1C50） of compounds 4a--4o to that of camptothecin（CPT） which appeared to be active against a broad range of human cancers. Among all the compounds, compound 41 shows the most potent biological activity against MG63 cells[IC50=（2.16i0.26） μmol/L] and B16-F10 cells[IC50=（6.95±0.24）μmol/L], thus providing useful information for the antitumor activity and potential practical use of isoquinolonic acid compounds. In addition, we screened out an efficient compound（41） that shows potential inhibit activity against Topoisomerase 1（Topo 1） by docking simulation.     

分子中部含齐聚氧化乙烯单元的酯-醚液晶

以4-(4′-烷氧基苯甲酰氧基)苯甲酸作为液晶中间体,合成了在分子中部含齐聚氧化乙烯的系列酯-醚液晶化合物.对其化学结构和液晶性能进行了表征,除个别化合物外,其余样品均具有热致液晶性.     

2-Amino-3-cyano-4H-chromene-4-ylphosphonates as potential antiviral agents: Synthesis,in ovo and in silico approach

A simplistic synthetic procedure for the synthesis of structurally diversified 2-amino-3-cyano-4H-chromene-4-ylphosphonates ( 4a-j ) were developed by the treatment of substituted salicylaldehydes, malononitrile, and dialkyl phosphite in presence of Cu(OAc)₂ catalyst at room temperature and neat conditions. The synthesized compounds were tested for their antiviral assay. Among all, the compounds 4a , 4d and 4h have shown good in ovo antiviral activity against New castle disease virus (NDV) at a concentration of 150 μg/mL. The remarkable reduction in NDV virus population in embryos treated with title compounds ( 4a-j ) in a dose dependent manner, indicated that the synthesized compounds are extreme by toxic to the NDV virus. The title compounds were also docked against hemagglutinin neuraminidase enzyme and the more bioactive compound 4a showed highest docking score than the standard antiviral drug taribavirin while the compounds 4d and 4h has the same docking score as that of the standard.     

Synthesis and transition temperatures of novel fluorinated chiral liquid crystals containing 1,4-tetrafluorophenylene units

To continue the search for novel series of fluorinated ferroelectric liquid crystals, an additional two series of 4-[(S)-2-methylbutoxy]phenyl 4-[(4-n-alkoxy-2,3,5,6-tetrafluorophenyl)ethynyl] benzoates (C) and 4-(n-alkoxy)phenyl 4-[(4-(S)-2'-methylbutoxy-2,3,5,6-tetrafluorophenyl)] benzoates (D) have been synthesized. Polarizing microscopic textural observations and DSC measurements of the phase transitions of these novel compounds showed that compounds C were liquid crystals with a chiral nematic (N) phase and a monotropic chiral smectic C phase (S_c), and compounds D exhibited a chiral nematic (N) phase.